page contents



Nechifor M. Magnesium in major depression. Magnes Res 2009;22:163S-166S.

Eby G, Eby K. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses 2010;74:649-660.

Szewczyk B, Poleszak E, Sowa-Kucma M et al. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 2008;60:588-589.

Eby G, Eby K. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006;67:362-70.

Mokhber N, Namjoo M, Tara F et al. Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal Med 2011;24:104-108.

Benton D, Cook R. The impact of selenium supplementation on mood. Biol Psychiatry 1991;29:1092-1098.

Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord 2000;60:121-130.

Miller A. The methylation, neurotransmitter and antioxidant connections between folate and depression. Altern Med Rev 2008;13:216-226.

Papakostas G, Petersen T, Mischoulon D et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 2004;65:1090-1095.

Wesson V, Levitt A, Joffe R. Change in folate status with antidepressant treatment. Psychiatry Res 1994;53:313-322.

Kate N, Grover S, Agarwal M. Does B12 deficiency lead to a lack of treatment response to conventional antidepressants? Psychiatry 2010;7:42-44

Hintikka J, Tolmunen T, Tanskanen A et al. High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry 2003:3:17.

Bhat A, Srinivasan K, Kurpad S et al. Psychiatric presentations of vitamin B12 deficiency. 2007;105:395-396.

Merete C, Falcon L, Tucker K. Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr 2008;27:421-427.

Williams A, Cotter A, Sabina A et al. The role for vitamin B-6 as treatment for depression: a systematic review. Fam Pract 2005;22:532-537.

Hvas A, Juul S, Bech P et al.  Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom 2004;73:340-343.

Miyake Y, Sasaki S, Tanaka K et al. Dietary folate and vitamins B12, B6 and B2 intake and the risk of postpartum depression in Japan: the Osaka Maternal and Child Health Study. J Affect Disord 2006;96:133-138

Bell I, Morrow F, Read M et al. Low thyroxine levels in female psychiatric in patients with riboflavin deficiency: implications for folate-dependent methylation. Acta Psychiatr Scand 1992;85:360-363.

Jorde R, Sneve M, Figenschau Y et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008;264:599-609.

Högberg G, Gustafsson SA, Hällström T et al. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatr 2012;101:779-783.

Berk M, Sanders K, Pasco J et al Vitamin D deficiency may play a role in depression. Med Hypotheses 2007;69:1316-1319.

22Smeland O, Meisingset T, Borges K et al. Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochem Int 2012;61:100-107.

Garzya G, Corallo D, Fiore A et al. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression. Drugs Exp Clin Res 1990;16:101-106.

Levine J, Barak Y, Gonzalves M et al. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 1995;152:792-794.

Brink C, Viljoen S, de Kock S e t al. Effects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells. Metab Brain Dis 2004;19:51-70.

Levenson J. Biotin-responsive depression during hyperalimentation. J Parenter Enteral Nutr 1983;7:181-183.

Osada K, Komai M et al. Experimental study of fatigue provoked by biotin deficiency in mice. Int J Vitam Nutr Res 2004;74:334-340.

Bodnar L, Wisner K. Nutrition and depression: Implications for improving mental health among child-bearing-aged women. Biol Psychiatry 2005;58:679-685.

Maes M, Mihaylova I, Kubera M et al. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 2009;30:462-469.

Tsuboi H, Shimoi K, Kinae N et al. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 2004;56:53-58.

de Koning T, Klomp L. Serine-deficiency syndromes. Curr Opin Neurol 2004;17:197-204.

Mitani H, Shirayama Y, Yamada T et al. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1155-1158.

Cope E, Levenson C. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care 2010;13:685-689.

Nowak G, Siwek M, Dudek D et al. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 2003;55:1143-1147.

Maes M, Vandoolaeghe E, Neels H et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Psychiatry 1997;42:349-358.

Levenson C. Zinc, the new antidepressant? Nutr Rev 2006;64:39-42.

Attenburrow M, Odontiadis J, Murray B et al. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Pychopharmacology 2002;159:432-436.

Docherty J, Sack D, Roffman M et al. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiatr Pract 2005;11:302-314.

Davidson J, Abraham K, Connor K et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261-264.

Additional references at